Irisin levels in genetic and essential obesity: clues for a potential dual role
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Irisin levels in genetic and essential obesity: clues for a potential dual role
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-23
DOI
10.1038/s41598-020-57855-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum uric acid potentially links metabolic health to measures of fuel use in lean and obese individuals
- (2018) C. Mele et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- The relationship between resting energy expenditure and thyroid hormones in response to short-term weight loss in severe obesity
- (2018) Paolo Marzullo et al. PLoS One
- Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
- (2018) Mychael V. Lourenco et al. NATURE MEDICINE
- Obesity management in Prader–Willi syndrome: current perspectives
- (2018) Antonino Crinò et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents
- (2017) Han Byul Jang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Physiology and role of irisin in glucose homeostasis
- (2017) Nikolaos Perakakis et al. Nature Reviews Endocrinology
- Association of Irisin Plasma Levels with Anthropometric Parameters in Children with Underweight, Normal Weight, Overweight, and Obesity
- (2017) Leticia Elizondo-Montemayor et al. Biomed Research International
- Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome
- (2017) Chiara Mele et al. Scientific Reports
- Diagnosis and treatment of GH deficiency in Prader–Willi syndrome
- (2016) Graziano Grugni et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Association between circulating irisin and insulin resistance in non-diabetic adults: A meta-analysis
- (2016) Shanhu Qiu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes
- (2015) T.-Y. Liu et al. CLINICAL SCIENCE
- Long-term Echocardiographic and Cardioscintigraphic Effects of Growth Hormone Treatment in Adults With Prader-Willi Syndrome
- (2015) Paolo Marzullo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum Irisin Levels Are Regulated by Acute Strenuous Exercise
- (2015) Dennis Löffler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Irisin and the Metabolic Phenotype of Adults with Prader-Willi Syndrome
- (2015) Harry J. Hirsch et al. PLoS One
- Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings
- (2015) M. A. Angulo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects
- (2014) G. Sesti et al. ACTA DIABETOLOGICA
- Irisin: ‘fat’ or artefact
- (2014) A.B. Crujeiras et al. CLINICAL ENDOCRINOLOGY
- Circulating Irisin in Healthy, Young Individuals: Day-Night Rhythm, Effects of Food Intake and Exercise, and Associations With Gender, Physical Activity, Diet, and Body Composition
- (2014) Athanasios D. Anastasilakis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Skeletal Muscle Characteristics and Motor Performance After 2-Year Growth Hormone Treatment in Adults With Prader-Willi Syndrome
- (2014) Claudio L. Lafortuna et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Irisin as a muscle-derived hormone stimulating thermogenesis – A critical update
- (2014) Tobias Hofmann et al. PEPTIDES
- Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index
- (2014) María Pardo et al. International Journal of Endocrinology
- Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women
- (2013) Ana B. Crujeiras et al. AMERICAN JOURNAL OF HUMAN BIOLOGY
- Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients
- (2013) Rocio de la Iglesia et al. CLINICAL ENDOCRINOLOGY
- Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling
- (2013) Y. Zhang et al. DIABETES
- Serum irisin levels in new-onset type 2 diabetes
- (2013) Yeon-Kyung Choi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Structure of Irisin Reveals a Novel Intersubunit β-Sheet Fibronectin Type III (FNIII) Dimer
- (2013) Maria A. Schumacher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome
- (2013) Kyung Hee Park et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance
- (2013) José María Moreno-Navarrete et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Irisin is inversely associated with intrahepatic triglyceride contents in obese adults
- (2013) Hui-Jie Zhang et al. JOURNAL OF HEPATOLOGY
- Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass
- (2013) Andrew G. Swick et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Irisin: A renaissance in metabolism?
- (2013) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients
- (2013) Ana B. Crujeiras et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine
- (2013) Arturo Roca-Rivada et al. PLoS One
- Evidence against a Beneficial Effect of Irisin in Humans
- (2013) Silja Raschke et al. PLoS One
- Prader-Willi syndrome
- (2012) Suzanne B. Cassidy et al. GENETICS IN MEDICINE
- FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise
- (2012) Joo Young Huh et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
- (2012) Pontus Boström et al. NATURE
- Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – Correlation with body mass index
- (2012) Andreas Stengel et al. PEPTIDES
- The role of lipid droplets in metabolic disease in rodents and humans
- (2011) Andrew S. Greenberg et al. JOURNAL OF CLINICAL INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started